* Presents positive 1-year follow-up data of its pivotal Phase II Trial with ATIR101
The post BRIEF-Kiadis Pharma presents positive follow-up data of ATIR101 Phase II trial appeared first on NASDAQ.
Forex – financial instrument.Forex news
* Presents positive 1-year follow-up data of its pivotal Phase II Trial with ATIR101
The post BRIEF-Kiadis Pharma presents positive follow-up data of ATIR101 Phase II trial appeared first on NASDAQ.